Third Wave to Provide Invader Technology for NIH Sponsored Study | GenomeWeb

NEW YORK, Jan 4 – Third Wave Technologies said Thursday it had licensed its Invader genotyping system to Fairview University Medical Center in Minneapolis for a genotyping study to be sponsored by the NIH. 

Terms of the deal were not disclosed, although Third Wave generally opts for deals that give the company rights to discoveries made using its technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.